Highlights
- Market Cap
- $56.16M
- Enterprise Value
- $42.20M
- EPS (TTM)
- $0.30
- PE Ratio
- 2.65
- Total Revenue (TTM)
- $209.00K
- Gross Profit (TTM)
- -$20.13M
- EBITDA (TTM)
- -$40.33M
- Year Range
- $0.22 - $3.70
- Target Price
- $5.50
- ROA (TTM)
- 9.40%
- ROE (TTM)
- 9.99%
Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Cypherpunk Technologies Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
Cypherpunk Technologies Inc (CYPH) has returned -31.50% so far this year and 160.44% over the past 12 months.
Cypherpunk Technologies Inc
- 1D
- 27.03%
- 1M
- 27.32%
- YTD
- -31.50%
- 6M
- 75.02%
- 1Y
- 160.44%
- 3Y*
- -38.40%
- 5Y*
- -47.11%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
Based on dividend-adjusted daily data since Jan 25, 2017, CYPH's average daily return is +0.13%, while the average monthly return is +1.96%. At this rate, your investment would double in approximately 3.0 years.
Historically, 38% of months were positive and 62% were negative. The best month was Nov 2025 with a return of +242.1%, while the worst month was Jan 2025 at -80.5%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 6 months.
On a daily basis, CYPH closed higher 44% of trading days. The best single day was Nov 12, 2025 with a return of +368.6%, while the worst single day was Jan 28, 2025 at -71.1%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -35.74% | -16.27% | 27.32% | -31.50% | |||||||||
| 2025 | -80.52% | -17.28% | -34.15% | 37.04% | -9.59% | -21.46% | 4.41% | -6.97% | 57.42% | -1.50% | 242.13% | -24.18% | -59.65% |
| 2024 | -27.62% | -7.00% | -4.66% | 16.54% | -21.61% | -19.34% | 9.18% | 35.51% | -11.38% | 45.53% | -20.32% | -3.52% | -30.64% |
| 2023 | 47.78% | -14.27% | -40.36% | 15.09% | 127.45% | -64.83% | -12.46% | -18.61% | -38.12% | 6.52% | 53.06% | 84.22% | -7.89% |
| 2022 | -40.12% | 2.58% | -12.06% | -26.29% | -16.28% | 6.48% | -9.57% | 36.54% | -38.03% | -3.30% | -28.95% | -25.57% | -86.11% |
| 2021 | 3.56% | 0.00% | -18.45% | -10.00% | -5.26% | 1.23% | -13.41% | 21.13% | 133.14% | -30.42% | -6.45% | 24.14% | 44.00% |
Benchmark Metrics
Cypherpunk Technologies Inc has an annualized alpha of 17.23%, beta of 1.19, and R² of 0.02 versus S&P 500 Index. Calculated based on daily prices since January 26, 2017.
- This stock participated in 131.05% of S&P 500 Index downside but only -64.24% of its upside — more exposed to losses than it benefited from rallies.
- R² of 0.02 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 17.23%
- Beta
- 1.19
- R²
- 0.02
- Upside Capture
- -64.24%
- Downside Capture
- 131.05%
Return for Risk
Risk / Return Rank
CYPH ranks 78 for risk / return — better than 78% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Cypherpunk Technologies Inc (CYPH) and compare them to a chosen benchmark (S&P 500 Index).
| CYPH | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.40 | 0.90 | -0.50 |
Sortino ratioReturn per unit of downside risk | 4.46 | 1.39 | +3.07 |
Omega ratioGain probability vs. loss probability | 1.53 | 1.21 | +0.32 |
Calmar ratioReturn relative to maximum drawdown | 1.83 | 1.40 | +0.43 |
Martin ratioReturn relative to average drawdown | 3.33 | 6.61 | -3.27 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Explore CYPH risk-adjusted metrics in detail
Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the Cypherpunk Technologies Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Cypherpunk Technologies Inc was 99.76%, occurring on Aug 14, 2025. The portfolio has not yet recovered.
The current Cypherpunk Technologies Inc drawdown is 99.21%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.76% | Apr 13, 2018 | 1845 | Aug 14, 2025 | — | — | — |
| -46.34% | Mar 9, 2017 | 157 | Oct 19, 2017 | 114 | Apr 5, 2018 | 271 |
| -28.81% | Jan 27, 2017 | 5 | Feb 2, 2017 | 22 | Mar 7, 2017 | 27 |
| -9% | Apr 6, 2018 | 1 | Apr 6, 2018 | 4 | Apr 12, 2018 | 5 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Cypherpunk Technologies Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Cypherpunk Technologies Inc is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for CYPH, comparing it with other companies in the Biotechnology industry. Currently, CYPH has a P/E ratio of 2.7. This P/E ratio is considered low compared to industry peers, which may suggest that the stock is undervalued or that the company has weaker growth prospects.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for CYPH relative to other companies in the Biotechnology industry. Currently, CYPH has a P/S ratio of 194.6. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for CYPH in comparison with other companies in the Biotechnology industry. Currently, CYPH has a P/B value of 0.4. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |